Massimo Mattia SANTORO
Has grant
Full Professor
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Massimo Mattia Santoro is a Full Professor at the University of Padua, Italy. His research primarily focuses on the intersection of metabolism and translation, particularly in the context of cancer and angiogenesis. Recent publications explore topics such as metabolic vulnerabilities in circulating tumor cells and the role of circadian proteins in endothelial cell function. He is actively involved in examining how metabolic rewiring affects tumor endothelial cells and vascular permeability.
Recent Grants
Grant: Close
UBIAD1 and ferroptosis: exploring a cure for Schnyder Corneal Dystrophy (SCD)
Open Date: 2021-09-01
Close Date:
Grant: Close
MELASTOP
Open Date: 2021-07-01
Close Date:
Grant: Close
Redox homeostasis in cancer progression: A critical functon for the antioxidant enzyme UBIAD1
Open Date: 2018-01-01
Close Date: 2021-12-01
Grant: Close
Rendox
Open Date: 2016-03-01
Close Date:
Grant: Close
ANGIOGENIC ANTIOXIDANT RESPONSE IN HEALTH AND DISEASE
Open Date: 2014-01-01
Close Date: 2018-12-01
Articles (13)
Year:
2025
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Collaborators (11)
Raquel Brañas Casas
University of Padua
Enrico Baruffini
Researcher, assistant professor
Università degli Studi di Pavia
Giulia Mana
Candiolo Cancer Institute, FPO-IRCCS
Maria Berica Rasotto
-
Andrea Vettori
Associate professor
University of Verona
Giovanni Risato
University of Padua
Donatella Valdembri
Candiolo Cancer Institute, FPO-IRCCS
Noemi Gioelli
Candiolo Cancer Institute, FPO-IRCCS
marco arese
Candiolo Cancer Institute, FPO-IRCCS
Nico Mitro
Università degli Studi di Perugia Dipartimento di Scienze Farmaceutiche
Guido Serini
Full Professor
University of Turin
Make your next move.
Prepare your application
Review drafts before you send them.